News

Elorac has launched Zithranol-RR (anthralin rapid release microcrystalline encapsulated cream, 1.2%) for the treatment of mild to moderate plaque psoriasis. Zithranol-RR is available by prescription in a 45gm

Facet Biotech and Trubion have signed an agreement for the joint worldwide development and commercialisation of TRU-016. TRU-016, a product candidate in phase 1 clinical development for chronic

Biotie has achieved a milestone in its collaboration with Wyeth for the development of PDE10 (phosphodiesterase 10) inhibitors for schizophrenia. Wyeth will trigger a $1.0m milestone payment to

The device was developed in collaboration Professor Donna Davies and Dr Judith Holloway from the University’s school of medicine, and Philips Research. The University said that the next

SOCMA had met with representatives of the EPA and the White House’s Office of Management and Budget (OMB) to discuss the batch chemical industry’s priorities for TSCA reform.

Bristol-Myers Squibb has reported that the initial tender offer for all outstanding shares of common stock of Medarex has expired on August 26, 2009, and was not extended.

Mylan Pharmaceuticals, a subsidiary of Mylan Inc, has started marketing 1% Clindamycin and 5% Benzoyl Peroxide Gel based on an agreement with licensing partner Dow Pharmaceutical Sciences, a

Kamada has entered into an agreement with a US specialty pharmaceutical distributor company for the distribution of its product, intravenous alpha-1 antitrypsin (AAT-IV) in the US. Under the

EcoActive Surfaces has released OxiTitan VLR, a light powered antimicrobial coating effective against viruses and bacteria indoors. OxiTitan VLR is designed to be used as an adjunct to